These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9292420)

  • 1. Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis.
    Graybill JR; Bocanegra R; Lambros C; Luther MF
    J Med Vet Mycol; 1997; 35(4):243-7. PubMed ID: 9292420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of D0870 and fluconazole in the treatment of murine cryptococcal meningitis.
    Correa AL; Velez G; Albert M; Luther M; Rinaldi MG; Graybill JR
    J Med Vet Mycol; 1995; 33(6):367-74. PubMed ID: 8683404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis.
    Ding JC; Bauer M; Diamond DM; Leal MA; Johnson D; Williams BK; Thomas AM; Najvar L; Graybill JR; Larsen RA
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1589-93. PubMed ID: 9210691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.
    Nguyen MH; Najvar LK; Yu CY; Graybill JR
    Antimicrob Agents Chemother; 1997 May; 41(5):1120-3. PubMed ID: 9145879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746.
    Restrepo MI; Najvar LK; Barchiesi F; Luther MF; Graybill JR
    Med Mycol; 2000 Jun; 38(3):221-4. PubMed ID: 10892990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole monotherapy for cryptococcosis in non-AIDS patients.
    Yamaguchi H; Ikemoto H; Watanabe K; Ito A; Hara K; Kohno S
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):787-92. PubMed ID: 8950555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis.
    Larsen RA; Bauer M; Weiner JM; Diamond DM; Leal ME; Ding JC; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2178-82. PubMed ID: 8878602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.
    Sudan A; Livermore J; Howard SJ; Al-Nakeeb Z; Sharp A; Goodwin J; Gregson L; Warn PA; Felton TW; Perfect JR; Harrison TS; Hope WW
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2793-800. PubMed ID: 23571544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis.
    Wiederhold NP; Najvar LK; Garvey EP; Brand SR; Xu X; Ottinger EA; Alimardanov A; Cradock J; Behnke M; Hoekstra WJ; Schotzinger RJ; Jaramillo R; Olivo M; Kirkpatrick WR; Patterson TF
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report. Granuloma caused by Cryptococcus neoformans.
    Hong W; Liao W; Gu J
    Mycoses; 2000; 43(1-2):71-4. PubMed ID: 10838852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans var neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia.
    Assing K; Birgens H; Arendrup M
    Clin Microbiol Infect; 2003 May; 9(5):441-4. PubMed ID: 12848761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
    Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
    J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS.
    Alves SH; Lopes JO; Costa JM; Klock C
    Rev Inst Med Trop Sao Paulo; 1997; 39(6):359-61. PubMed ID: 9674289
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryptococcal meningitis presenting as sinusitis in a renal transplant recipient.
    Iyer SP; Movva K; Wiebel M; Chandrasekar P; Alangaden G; Carron M; Tranchida P; Revankar SG
    Transpl Infect Dis; 2013 Oct; 15(5):E187-90. PubMed ID: 24034280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
    Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
    J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis.
    Velez JD; Allendoerfer R; Luther M; Rinaldi MG; Graybill JR
    J Infect Dis; 1993 Aug; 168(2):508-10. PubMed ID: 8335995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.